K. Raghavan

发表

Integrating the Synergy of the Gut Microbiome into Regenerative Medicine: Relevance to Neurological Disorders

N. Ranganathan, S. Preethy, K. Raghavan, 2022, Journal of Alzheimer's disease : JAD.

Disease-modifying immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in young boys with Duchenne muscular dystrophy: Results of an open-label, prospective, randomized, comparative clinical study

S. Preethy, K. Raghavan, V. Dedeepiya, 2021, medRxiv.

Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study

S. Preethy, K. Raghavan, V. Dedeepiya, 2021, Biomedicine & Pharmacotherapy.

Potentials to alleviate coagulopathy and enhance microglial function of beta (β)- glucans, making them worth a clinical study for COVID-19's neurological sequalae

K. Raghavan, N. Ikewaki, S. Abraham, 2021, Journal of the Neurological Sciences.

Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis

V. Surya Prakash, S. Preethy, K. Raghavan, 2022, Frontiers in Immunology.

Beneficial immune-regulatory effects of novel strains of Aureobasidium pullulans AFO-202 and N-163 produced beta glucans in Sprague Dawley rats

S. Preethy, K. Raghavan, V. Dedeepiya, 2021, Clinical Immunology Communications.

Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential for applications in human health and disease

N. Ranganathan, S. Preethy, K. Raghavan, 2022, bioRxiv.

Efficient control of IL-6, and in Covid-19 patients with two variants of Beta-1,3-1,6 glucans in combination, within 15 days in an open-label prospective clinical trial Control of IL-6, CRP and Ferritin in Covid-19 patients with Beta Glucans

K. Raghavan, N. Ikewaki, S. Seshayyan, 2022 .

Efficient control of IL-6, CRP and Ferritin in Covid-19 patients with two variants of Beta-1,3-1,6 glucans in combination, within 15 days in an open-label prospective clinical trial

S. Preethy, K. Raghavan, V. Dedeepiya, 2021, medRxiv.

Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study

S. Preethy, K. Raghavan, V. Dedeepiya, 2021, Biomedicine & Pharmacotherapy.

β‑glucan vaccine adjuvant approach for cancer treatment through immune enhancement (B‑VACCIEN) in specific immunocompromised populations (Review).

S. Preethy, K. Raghavan, V. Dedeepiya, 2021, Oncology reports.

Randomised trial of Aureobasidium pullulans-produced beta 1,3-1,6-glucans in patients with Duchenne muscular dystrophy: Favourable changes in gut microbiota and clinical outcomes indicating their potential in epigenetic manipulation

S. Preethy, K. Raghavan, V. Dedeepiya, 2022, medRxiv.

Efficacy of N-163 strain of Aureobasidium pullulans-produced beta-glucan in improving muscle strength and function in patients with Duchenne muscular dystrophy; Results of a 6-month non-randomised open-label linear clinical trial

S. Preethy, K. Raghavan, V. Dedeepiya, 2023, medRxiv.

Benefits of Gut Microbiota Reconstitution by Beta 1,3–1,6 Glucans in Subjects with Autism Spectrum Disorder and Other Neurodegenerative Diseases

S. Preethy, K. Raghavan, V. Dedeepiya, 2022, Journal of Alzheimer's disease : JAD.

Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomised, parallel-group pilot clinical study

S. Preethy, K. Raghavan, V. Dedeepiya, 2021, BMJ Neurology Open.

Is phototherapy a risk factor for ileus in high-risk neonates?

R. Muller, S. Patole, K. Raghavan, 2005, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study

S. Preethy, K. Raghavan, V. Dedeepiya, 2023, IBRO Neuroscience Reports.

Re-examination of therapeutic management of muscular dystrophies using a vascular smooth muscle-centered approach

S. Preethy, K. Raghavan, V. Dedeepiya, 2023, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi.

Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential applications in human health and disease

N. Ranganathan, S. Preethy, K. Raghavan, 2022, BMJ open gastroenterology.

Improvement of sleep patterns and serum melatonin levels in children with autism spectrum disorders after consumption of beta-1,3/1,6-glucan in a pilot clinical study

S. Preethy, K. Raghavan, V. Dedeepiya, 2021 .